Axsome Therapeutics Inc: Patents

View up-to-date information on Axsome Therapeutics Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
US20220280524A1	Application	REBOXETINE TO TREAT NARCOLEPSY	A61K31/5375; A61P25/02; A61P25/20	September 08, 2022
US11433035B2	Grant	Dosage forms and methods for enantiomerically enriched or pure bupropion	A61K31/137; A61K9/0053; A61K9/0095; A61K9/20; A61K9/48	September 06, 2022
US11433078B2	Grant	Pharmaceutical compositions comprising meloxicam	A61K31/4196; A61K31/5415; A61K33/00; A61K47/02; A61K47/40; A61K47/6951; A61P25/06	September 06, 2022
US11433079B2	Grant	Pharmaceutical compositions comprising meloxicam	A61K31/4196; A61K31/5415; A61K47/02; A61K47/61; A61P1/08; A61P25/06; A61P29/00	September 06, 2022
US11426414B2	Grant	Pharmaceutical compositions comprising meloxicam	A61K31/4196; A61K31/5415; A61K47/02; A61K47/40; A61K47/6951; A61K9/0053; A61K9/2009; A61K9/205; A61K9/2086; A61K9/209; A61P29/00	August 30, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Contact Us

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Contact Us

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Contact the team or request a demo to find out how our data can drive your business forward